202 related articles for article (PubMed ID: 37470827)
1. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
Poetter-Lang S; Messner A; Bastati N; Ringe KI; Ronot M; Venkatesh SK; Ambros R; Kristic A; Korajac A; Dovjak G; Zalaudek M; Hodge JC; Schramm C; Halilbasic E; Trauner M; Ba-Ssalamah A
Eur Radiol; 2023 Dec; 33(12):9022-9037. PubMed ID: 37470827
[TBL] [Abstract][Full Text] [Related]
2. Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications.
Kinner S; Schubert TB; Said A; Mezrich JD; Reeder SB
Eur Radiol; 2017 Oct; 27(10):4415-4425. PubMed ID: 28409358
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance cholangiography in the diagnosis of dominant strictures in pediatric-onset primary sclerosing cholangitis.
Vanhanen E; Ovissi A; Kolho KL; Tenca A
Dig Liver Dis; 2023 Nov; 55(11):1496-1501. PubMed ID: 37286450
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis.
Frydrychowicz A; Jedynak AR; Kelcz F; Nagle SK; Reeder SB
J Magn Reson Imaging; 2012 Sep; 36(3):632-40. PubMed ID: 22581411
[TBL] [Abstract][Full Text] [Related]
6. MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.
Bookwalter CA; Venkatesh SK; Eaton JE; Smyrk TD; Ehman RL
Abdom Radiol (NY); 2018 Dec; 43(12):3260-3270. PubMed ID: 29626258
[TBL] [Abstract][Full Text] [Related]
7. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
8. Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis.
Cazzagon N; Chazouillères O; Corpechot C; El Mouhadi S; Chambenois E; Desaint B; Chaput U; Lemoinne S; Arrivé L
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):387-394. PubMed ID: 30772328
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.
Moff SL; Kamel IR; Eustace J; Lawler LP; Kantsevoy S; Kalloo AN; Thuluvath PJ
Gastrointest Endosc; 2006 Aug; 64(2):219-23. PubMed ID: 16860072
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Berstad AE; Aabakken L; Smith HJ; Aasen S; Boberg KM; Schrumpf E
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):514-20. PubMed ID: 16616358
[TBL] [Abstract][Full Text] [Related]
11. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
12. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic workup of primary sclerosing cholangitis: the benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography.
Nolz R; Asenbaum U; Schoder M; Wibmer A; Einspieler H; Prusa AM; Peck-Radosavljevic M; Ba-Ssalamah A
Clin Radiol; 2014 May; 69(5):499-508. PubMed ID: 24630133
[TBL] [Abstract][Full Text] [Related]
14. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis.
Vitellas KM; Enns RA; Keogan MT; Freed KS; Spritzer CE; Baillie J; Nelson RC
AJR Am J Roentgenol; 2002 Feb; 178(2):327-34. PubMed ID: 11804887
[TBL] [Abstract][Full Text] [Related]
16. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
17. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
19. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
[TBL] [Abstract][Full Text] [Related]
20. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
